Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HF.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.42.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.517EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.427 (Epsilon)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.429 (Epsilon)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.166EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
AY.99.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KT.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.334EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.359EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.302EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.222EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.434EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.467EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.110.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.23 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.9 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.74 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.621.1 (Mu)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.67EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.16.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.72EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.73EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDZEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XEBEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.263EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.180EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.464EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.234EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.231EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.243EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.517EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.291EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.349EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.314EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used